In this study of 44 patients with ESKD who were predialysis ESKD PD candidates, we observed that a high sclerostin (≥ 218.18 pmol/L) level was associated with pulmonary hypertension and deleterious echocardiographic parameters. Here, SOST is linked to pulmonary hypertension.